Profile
Herbert Raymond Henney worked as a Senior Director-Medical Affairs at Savient Pharmaceuticals, Inc. and as a Vice President-Clinical & Regulatory Affairs at W World Corp.
He also worked at Acorda Therapeutics, Inc. as a Vice President-Clinical Development from 2011 to 2014.
Henney holds a doctorate degree from the Medical University of South Carolina and an undergraduate degree from Temple University (Pennsylvania).
Former positions of Herbert Raymond Henney
| Companies | Position | End |
|---|---|---|
| ACORDA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2014-03-31 |
| SAVIENT PHARMACEUTICALS INC | Chief Tech/Sci/R&D Officer | - |
| W WORL | Chief Tech/Sci/R&D Officer | - |
Training of Herbert Raymond Henney
| Medical University of South Carolina | Doctorate Degree |
| Temple University (Pennsylvania) | Undergraduate Degree |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| W WORL | Health Technology |
| ACORDA THERAPEUTICS, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Savient Pharmaceuticals, Inc.
 Savient Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Savient Pharmaceuticals, Inc. operates as a specialty biopharmaceutical company, which develops, manufactures and markets pharmaceutical products. The company focuses on developing and commercializing KRYSTEXXA for the treatment of chronic gout in adult patients who do not respond to conventional therapy. It also sells and distributes branded and generic versions of oxandrolone, a drug used to promote weight gain following involuntary weight loss. The company was founded in 1980 is headquartered in East Brunswick, NJ. | Health Technology |
- Stock Market
- Insiders
- Herbert Raymond Henney